BMP-2 and TGFβ2 shared pathways regulate endocardial cell transformation

Cells Tissues Organs

Volumn 194, Issue 1, 2011, Pages 1-12

  Townsend, Todd A ^a   Robinson, Jamille Y ^a   Deig, Christopher R ^a   Hill, Cynthia R ^a   Misfeldt, Andrew ^a   Blobe, Gerard C ^b   Barnett, Joey V ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrioventricular cushion; Epithelial mesenchymal transformation; Heart valve; Receptors; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ARTICLE; ATRIOVENTRICULAR CANAL; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; ENDOCARDIUM; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CHICK EMBRYO; ENDOCARDIUM; HUMANS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 79959379262     PISSN: 14226405     EISSN: 14226421     Source Type: Journal    
DOI: 10.1159/000322035     Document Type: Article

References (74)

1. Bakin, A.V., C. Rinehart, A.K. Tomlinson, C.L. Arteaga (2002) p38 mitogen-activated protein kinase is required for TGFbeta-mediat-ed fibroblastic transdifferentiation and cell migration. J Cell Sci 115: 3193-3206.
2. Bakin, A.V., A.K. Tomlinson, N.A. Bhowmick, H.L. Moses, C.L. Arteaga (2000) Phosphati-dylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810. (Pubitemid 32002090)
3. Barnett, J.V., J.S. Desgrosellier (2003) Early events in valvulogenesis: a signaling perspective. Birth Defects Res C Embryo Today 69: 58-72. (Pubitemid 37238416)
4. Bartram, U., D.G. Molin, L.J. Wisse, A. Mohamad, L.P. Sanford, T. Doetschman, C.P. Speer, R.E. Poelmann, A.C. Gittenberger-de Groot (2001) Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endo-cardial cushion differentiation, and apopto-sis in TGF-beta(2)-knockout mice. Circulation 103: 2745-2752. (Pubitemid 32538792)
5. Bernanke, D.H., R.R. Markwald (1982) Migratory behavior of cardiac cushion tissue cells in a collagen-lattice culture system. Dev Biol 9 1: 235-245. (Pubitemid 12006844)
6. Bhowmick, N.A., M. Ghiassi, M. Aakre, K. Brown, V. Singh, H. L. Moses (2003) TGF-be-ta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci USA 100: 15548-15553. (Pubitemid 38021027)
7. Bhowmick, N.A., M. Ghiassi, A. Bakin, M. Aakre, C.A. Lundquist, M.E. Engel, C.L. Arteaga, H.L. Moses (2001) Transforming Growth Factor-beta1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism. Mol Biol Cell 12: 27-36. (Pubitemid 32060576)
8. Blobe, G.C., X. Liu, S.J. Fang, T. How, H.F. Lodish (2001a) A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling: functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 276: 39608-39617.
9. Blobe, G.C., W.P. Schiemann, M.C. Pepin, M. Beauchemin, A. Moustakas, H.F. Lodish, M.D. O'Connor-McCourt (2001b) Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J Biol Chem 276: 24627-24637.
10. Bose, R., J.L. Wrana (2006) Regulation of Par6 by extracellular signals. Curr Opin Cell Biol 18: 206-212. (Pubitemid 43375890)
11. Brown, C.B., A.S. Boyer, R.B. Runyan, J.V. Bar-nett (1996) Anti bodies to the type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev Biol 174: 248-257. (Pubitemid 26135192)
12. Brown, C.B., A.S. Boyer, R.B. Runyan, J.V. Bar-nett (1999) Requirement of type III TGF-be-ta receptor for endocardial cell transformation in the heart. Science 283: 2080-2082.
13. Bryan, B., Y. Cai, K. Wrighton, G. Wu, X.H. Feng, M. Liu (2005) Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. FEBS Lett 579: 101 5-1019. (Pubitemid 40248662)
14. Bushdid, P.B., C.L. Chen, D.M. Brantley, F. Yull, R. Raghow, L.D. Kerr, J.V. Barnett (2001) NF-kappaB mediates FGF signal regulation of msx-1 expression. Dev Biol 237: 107-115. (Pubitemid 32844309)
15. Cheifetz, S., T. Bellon, C. Cales, S. Vera, C. Ber-nabeu, J. Massague, M. Letarte (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267: 19027-19030.
16. Chen, W., K.C. Kirkbride, T. How, C.D. Nelson, J. Mo, J.P. Frederick, X.F. Wang, R.J. Lefko-witz, G.C. Blobe (2003) Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301: 1394-1397. (Pubitemid 37075818)
17. Compton, L.A., D.A. Potash, C.B. Brown, J.V. Barnett (2007) Coronary vessel development is dependent on the type III transforming growth factor beta receptor. Circ Res 101: 784-791. (Pubitemid 350287193)
18. Deaton, R.A., C. Su, T.G. Valencia, S.R. Grant (2005) Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem 280: 31172-31181. (Pubitemid 41291854)
19. Dejana, E., R. Spagnuolo, G. Bazzoni (2001) In-terendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86: 308-315. (Pubitemid 32663961)
20. Desgrosellier, J.S., N.A. Mundell, M.A. McDonnell, H.L. Moses, J.V. Barnett (2005) Ac-tivin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 280: 201-210. (Pubitemid 40342753)
21. Dong, M., T. How, K.C. Kirkbride, K.J. Gordon, J.D. Lee, N. Hempel, P. Kelly, B.J. Moeller, J.R. Marks, G.C. Blobe (2007) The type III TGF-beta receptor suppresses breast cancer progression. J Clin Invest 117: 206-217. (Pubitemid 46048467)
22. Edlund, S., M. Landstrom, C.-H. Heldin, P. As-penstrom (2002) Transforming growth factor-beta-induced mobilization of actin cyto-skeleton requires signaling by small GTPases Cdc42 and R hoA. Mol Biol Cell 13: 902-914. (Pubitemid 34250354)
23. Finger, E.C., N.Y. Lee, H.J. You, G.C. Blobe (2008a) Endocytosis of the type III TGF-beta receptor through the clathrin-independent/ lipid raft pathway regulates TGF-beta signaling and receptor downregulation. J Biol Chem 283: 34808-34818.
24. Finger, E.C., R.S. Turley, M. Dong, T. How, T.A. Fields, G.C. Blobe (2008b) TbetaRIII suppresses non-small cell lung cancer invasive-ness and tumorigenicity. Carcinogenesis 29: 528-535. (Pubitemid 351404868)
25. Galvin, K.M., M.J. Donovan, C.A. Lynch, R.I. Meyer, R.J. Paul, J.N. Lorenz, V. Fairchild-Huntress, K.L. Dixon, J.H. Dunmore, M.A. Gimbrone Jr, D. Falb, D. Huszar (2000) A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24: 171-174. (Pubitemid 30094719)
26. Gordon, K.J., M. Dong, E.M. Chislock, T.A. Fields, G.C. Blobe (2008) Loss of type III transforming growth factor beta receptor expression increases motility and invasive-ness associated with epithelial to mesenchy-mal transition during pancreatic cancer progression. Carcinogenesis 29: 252-262. (Pubitemid 351359663)
27. Gordon, K.J., K.C. Kirkbride, T. How, G.C. Blobe (2009) Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcino-genesis 30: 238-248.
28. Hata, A., G. Lagna, J. Massague, A. Hemmati-Brivanlou (1998) Smad6 inhibits BMP/ Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186-197. (Pubitemid 28060449)
29. Hayashida, T., M. Decaestecker, H.W. Schnaper (2003) Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 17: 1576-1578.
30. he, T.C., S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, B. Vogelstein (1998) A simplified system for generating recombinant adenovi-ruses. Proc Natl Acad Sci USA 95: 2509-2514. (Pubitemid 28145972)
31. hempel, N., T. How, M. Dong, S.K. Murphy, T.A. Fields, G.C. Blobe (2007) Loss of betaglycan expression in ovarian cancer: role in motility and invasion. Cancer Res 67: 5231-5238. (Pubitemid 46997261)
32. Keller, B.B., R.R. Markwald (1998) Embryology of the heart; in Alexander, R.W., R.C. Schlant, V. Fuster (eds): Hurst's the Heart, Arteries and Veins. New York, McGraw-Hill, pp 195-212.
33. Kirkbride, K.C., B.N. Ray, G.C. Blobe (2005) Cell-surface co-receptors: emerging roles in signaling and human disease. Trends Biochem Sci 30: 611-621. (Pubitemid 41540081)
34. Kirkbride, K.C., T.A. Townsend, M.W. Bruins-ma, J.V. Barnett, G.C. Blobe (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283: 7628-7637.
35. Kretzschmar, M., J. Massague (1998) SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev 8: 103-111. (Pubitemid 28122148)
36. Lai, Y.T., K.B. Beason, G.P. Brames, J.S. Desgro-sellier, M.C. Cleggett, M.V. Shaw, C.B. Brown, J.V. Barnett (2000) Activin receptorlike kinase 2 can mediate atrioventricular cushion transformation. Dev Biol 222: 1-11. (Pubitemid 30387725)
37. Lee, N.Y., K.C. Kirkbride, R.D. Sheu, G.C. Blobe (2009) The transforming growth factor-beta type III receptor mediates distinct subcellu-lar trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors. Mol Biol Cell 20: 4362-4370.
38. Levy, L., C.S. Hill (2005) Smad4 dependency defines two classes of transforming growth factor beta (TGF-beta) target genes and distinguishes TGF-beta-induced epithelial-mes-enchymal transition from its antiproliferative and migratory responses. Mol Cell Biol 25: 8108-8125. (Pubitemid 41263004)
39. Livak, K.J., T.D. Schmittgen (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
40. Lopez-Casillas, F., S. Cheifetz, J. Doody, J.L. Andres, W.S. Lane, J. Massague (1991) Structure and expression of the membrane proteogly-can betaglycan, a component of the TGF-be-ta receptor system. Cell 67: 785-795. (Pubitemid 121001491)
41. Lopez-Casillas, F., J.L. Wrana, J. Massague (1993) Betaglycan present sligand to the TGF beta signa ling receptor. Cell 73: 1435-1444.
42. Ma, L., M.F. Lu, R.J. Schwartz, J.F. Martin (2005) Bmp2 is essential for cardiac cushion epithe-lial-mesenchymal transition and myocardial patterning. Development 132: 5601-5611. (Pubitemid 43125885)
43. Masszi, A., C. Di Ciano, G. Sirokmany, W.T. Arthur, O.D. Rotstein, J. Wang, C.A. Mc-Culloch, L. Rosivall, I. Mucsi, A. Kapus (2003) Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 284: F911-F924. (Pubitemid 36443575)
44. Mercado-Pimentel, M.E., A.D. Hubbard, R.B. Runyan (2007) Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 304: 420-432. (Pubitemid 46399690)
45. Miyazono, K., S. Maeda, T. Imamura (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16: 251-263. (Pubitemid 40910315)
46. Mythreye, K., G.C. Blobe (2009a) Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. Cell Signal 21: 1548-1558.
47. Mythreye, K., G.C. Blobe (2009b) The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arres-tin2-mediated activation of Cdc42. Proc Natl Acad Sci USA 106: 8221-8226.
48. Nakajima, A., Y. Ito, M. Asano, M. Maeno, K. Iwata, N. Mitsui, N. Shimizu, X.M. Cui, C.F. Shuler (2007) Functional role of transforming growth factor-beta type III receptor during palatal fusion. Dev Dyn 236: 791-801. (Pubitemid 46449190)
49. Ozdamar, B., R. Bose, M. Barrios-Rodiles, H.R. Wang, Y. Zhang, J.L. Wrana (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307: 1603-1609. (Pubitemid 40354739)
50. Potenta, S., E. Zeisberg, R. Kalluri (2008) The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99: 1375-1379.
51. Reeves, R., D.D. Edberg, Y. Li (2001) Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol 21: 575-594. (Pubitemid 32037376)
52. Rivera-Feliciano, J., C.J. Tabin (2006) Bmp2 instructs cardiac progenitors to form the heart-va lve-inducing field. Dev Biol 295: 580-588. (Pubitemid 43927695)
53. Sadler, T. (1985) Cardiovascular system; in Sadler, T.W. (ed): Langman's Medical Embryology. Baltimore, Williams and Wilkins, pp 168-195.
54. Sahai, E., R. Garcia-Medina, J. Pouyssegur, E. Vial (2007) Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol 176: 35-42. (Pubitemid 46041678)
55. Sanford, L.P., I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, G.P. Boivin, E.L. Cardell, T. Doetschman (1997) TGFbe-ta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124: 2659-2670. (Pubitemid 27341765)
56. Shi, Y., J. Massague (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
57. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. A l len, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, T. Doetschman (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
58. Song, L., R. Fassler, Y. Mishina, K. Jiao, H.S. Baldwin (2007) Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. Dev Biol 301: 276-286. (Pubitemid 44958389)
59. Stenvers, K.L., M.L. Tursky, K.W. Harder, N. Kountouri, S. Amatayakul-Chantler, D. Grail, C. Small, R.A. Weinberg, A.M. Size-land, H.J. Zhu (2003) Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol 23: 4371-4385. (Pubitemid 36666437)
60. Sugi, Y., H. Yamamura, H. Okagawa, R.R. Mark-wald (2004) Bone morphogenetic protein-2 can mediate myocardial regulation of atrio-ventricular cushion mesenchymal cell formation in mice. Dev Biol 269: 505-518. (Pubitemid 38521114)
61. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454
62. Townsend, T. A., J. L. Wrana, G.E. Davis, J.V. Barnett (2008) Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA. J Biol Chem 283: 13834-13841.
63. Turley, R.S., E.C. Finger, N. Hempel, T. How, T.A. Fields, G.C. Blobe (2007) The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Cancer Res 67: 1090-1098.
64. Wallez, Y., P. Huber (2007) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1 7 7 8: 79 4-8 0 9.
65. Wang, H.R., Y. Zhang, B. Ozdamar, A.A. Ogunjimi, E. Alexandrova, G.H. Thomsen, J.L. Wrana (2003) Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302: 1775-1779. (Pubitemid 37505743)
66. Wang, J., S. Sridurongrit, M. Dudas, P. Thomas, A. Nagy, M.D. Schneider, J.A. Epstein, V. Kaartinen (2005) Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev Biol 286: 299-310. (Pubitemid 41394064)
67. Wang, X.F., H.Y. Lin, E. Ng-Eaton, J. Downward, H.F. Lodish, R.A. Weinberg (1991) Expression cloning and characterization of the TGF-beta type III receptor. Cell 67: 797-805. (Pubitemid 121001492)
68. Ward, S.M., A.P. Gadbut, D. Tang, A.G. Papa-george, L. Wu, G. Li, J.V. Barnett, J.B. Galper (2002) TGFbeta regulates the expression of G alpha(i2) via an effect on the localization of ras. J Mol Cell Cardiol 34: 1217-1226 (Pubitemid 35205167)
69. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura, J. Massague (1994) Mechanism of activation of the TGF-beta receptor. Nature 370: 341-347 (Pubitemid 2110860)
70. Xie, L., B.K. Law, A. M. Chytil, K.A. Brown, M.E. Aakre, H.L. Moses (2004) Activation of the Erk pathway is required for TGF-beta1-in-duced EMT in vitro. Neoplasia 6: 603-610. (Pubitemid 39411098)
71. You, H.J., M.W. Bruinsma, T. How, J.H. Ostrander, G.C. Blobe (2007) The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis 28: 2491-2500. (Pubitemid 350238951)
72. You, H.J., T. How, G.C. Blobe (2009) The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. Carcinogenesis 30: 1281-1287.
73. Zeisberg, E.M., O. Tarnavski, M. Zeisberg, A.L. Dorfman, J.R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W.T. Pu, A.B. Roberts, E.G. Neilson, M.H. Sayegh, S. Izumo, R. Kalluri (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961. (Pubitemid 47222040)
74. Zhao, G.Q. (2003) Consequences of knocking out BMP signaling in the mouse. Genesis 35: 43-56.